India / 200% Pharma Sector Budget Boost; 3x Industry Growth in Next Decade; Pfizer Vaccine Rebuffed
The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…
Dr. Reddy’s Laboratories India
Last updated: 04.12.2018
Dr. Reddy’s commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas.
As a fully integrated pharmaceutical company, Dr Reddy’s provides medicines through three core businesses:
Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses;
– Global Generics, which includes branded and unbranded generics; and
– Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations,
-Biopharmaceuticals
Related
India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
India / Six Companies at the Forefront of COVID-19 Vaccine Development
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
Supply Chain / Indian Pharma Manufacturing: Back in Business
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
India / Biocon's New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
Gujarat / The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Pharma Faces / Vivek Sharma, PPS
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
China: Indian Pharma Firms Incoming
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
India Healthcare: “Modicare” Lives On
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
